Eleftherios Mylonakis
Physician · Houston Methodist Hospital
Credentials: · · · · · · ·
History
- 2026–Present
- 1999–2001
Infectious Diseases | Massachusetts General Hospital and Brigham and Women's Hospital |
- 1995–1998
- 1989–1992
- 1986–1990
Research
Infective endocarditis in adults
Review · New England Journal of Medicine · 2001 · First of 2 authors · 887 citations
Systematic review or meta-analysis · Clinical Infectious Diseases · 2017 · 472 citations
Medically important bacterial-fungal interactions
Review · Nature Reviews Microbiology · 2010 · Last of 3 authors · 463 citations
46 papers
39 papers · 29 as a resident
33 papers · 12 as a resident
22 papers
18 papers · 15 as a resident
18 papers · 14 as a resident
- SV
17 papers · 14 as a resident
- SC
17 papers
Grants
- 2026–2031
National Institute of Dental and Craniofacial Research · R01
Contact PI · $363.4K · Methodist Hospital Research Institute
- 2024–2029
Natural Phenolic Compounds Against Oral Candidiasis (OC)
National Institute of Allergy and Infectious Diseases · R01
Contact PI · $1.2M · Methodist Hospital Research Institute
- 2009–2027
Harvard-Wide Program on Antibiotic Resistance
National Institute of Allergy and Infectious Diseases · P01
PI · $12.9M · Massachusetts Eye and Ear Infirmary
- 2018–2023
COBRE Center for Antimicrobial Resistance and Therapeutic Discovery
National Institute of General Medical Sciences · P20
Contact PI · $7.6M · Miriam Hospital
Clinical trials
- 2020–2023
Thymalfasin (Thymosin Alpha 1) to Treat COVID-19 Infection
Principal investigator · Terminated · Phase 2
Rhode Island Hospital